0001415889-22-001059.txt : 20220203
0001415889-22-001059.hdr.sgml : 20220203
20220203191039
ACCESSION NUMBER: 0001415889-22-001059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harmon Cyrus
CENTRAL INDEX KEY: 0001831410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 22590301
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-02032022_040230.xml
X0306
4
2022-02-01
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831410
Harmon Cyrus
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
true
true
false
false
CHIEF TECHNOLOGY OFFICER
Stock Option (Right to Buy)
7.02
2022-02-01
4
A
0
104500
0
A
2032-01-31
Common Stock
104500
104500
D
25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2022-02-03